Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00712244 · ClinicalTrials.gov registry record · Phase 4
DisCoVisc Versus DuoVisc, Healon5 and AmVisc Plus
A Phase 4 study, sponsored by Alcon Research.
- Completed
- Registry status
- Phase 4
- Development phase
- 112
- Enrollment target
NCT00712244 is a Phase 4 study that has completed, run by Alcon Research. The registered enrollment target is 112 participants.
The verdict
NCT00712244, a Phase 4 study, has completed, sponsored by Alcon Research.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 112 participants
- Enrollment target
Study Summary
A comparison of the ability of DisCoVisc to that of other ophthalmic viscosurgical devices (OVDs) (DuoVisc, Healon5 or Amvisc PLUS) regarding endothelial protection and anterior chamber space maintenance during non-eventful cataract surgery.
Interventions
- DEVICE DisCoVisc
- DEVICE DuoVisc
- DEVICE Healon5
- DEVICE Amvisc Plus
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 112 participants |
| Start Date | 2007-10 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00712244
The ClinicalTrials.gov registry entry for NCT00712244 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 112 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Alcon Research, which has 275 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which DisCoVisc is the first listed.
NCT00712244 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00712244 about?
NCT00712244 is a clinical study titled "DisCoVisc Versus DuoVisc, Healon5 and AmVisc Plus". A comparison of the ability of DisCoVisc to that of other ophthalmic viscosurgical devices (OVDs) (DuoVisc, Healon5 or Amvisc PLUS) regarding endothelial protection and anterior chamber space maintenance during non-eventful cataract surgery.
What is the current status of trial NCT00712244?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 112 participants. The study started on 2007-10.
What interventions are being tested in trial NCT00712244?
The interventions under investigation include: DisCoVisc (DEVICE), DuoVisc (DEVICE), Healon5 (DEVICE), Amvisc Plus (DEVICE).
Who is sponsoring clinical trial NCT00712244?
This trial is sponsored by Alcon Research, which has 275 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.